104 related articles for article (PubMed ID: 4172726)
1. Transfusion of specific plasma components.
Tullis JL; Pennell RB
Annu Rev Med; 1968; 19():233-46. PubMed ID: 4172726
[No Abstract] [Full Text] [Related]
2. TRANSFUSION OF BLOOD FRACTIONS.
SALSBURY AJ
Practitioner; 1965 Aug; 195():193-200. PubMed ID: 14328859
[No Abstract] [Full Text] [Related]
3. Optimal use of blood components and derivatives.
Walter WJ; Oberman HA
Otolaryngol Clin North Am; 1981 Aug; 14(3):739-53. PubMed ID: 6795570
[No Abstract] [Full Text] [Related]
4. [Treatment with blood and blood plasma fractions].
Weise W
Dtsch Med J; 1967 Feb; 18(3):63-6. PubMed ID: 4174358
[No Abstract] [Full Text] [Related]
5. TRANSMISSION OF HEPATITIS BY BLOOD AND BLOOD PRODUCTS.
MAYCOCK WD
Proc R Soc Med; 1964 Nov; 57(11):1077-80. PubMed ID: 14226771
[No Abstract] [Full Text] [Related]
6. [Specific hemotherapy].
Stich W
Internist (Berl); 1969 Feb; 10(2):52-8. PubMed ID: 4188581
[No Abstract] [Full Text] [Related]
7. SERUM AND PLASMA PROTEINS IN THERMALLY INJURED PATIENTS TREATED WITH PLASMA, ITS ADMIXTURE WITH ALBUMIN OR SERUM ALONE.
BAAR S
Ann Surg; 1965 Jan; 161(1):112-26. PubMed ID: 14252621
[No Abstract] [Full Text] [Related]
8. Use of blood components in clinical practice. Blood components.
Norris BF
N Y State J Med; 1971 Jun; 71(12):1518-22. PubMed ID: 4102706
[No Abstract] [Full Text] [Related]
9. Multi-channel preparation of fresh blood an economic therapy with blood components.
Schneider W; Glassner K; Fröhlich C; McCarty LJ
Blut; 1974 Feb; 28(2):100-8. PubMed ID: 4130177
[No Abstract] [Full Text] [Related]
10. Plasma fractionation in the United States. A review for clinicians.
Ness PM; Pennington RM
JAMA; 1974 Oct; 230(2):247-50. PubMed ID: 4137885
[No Abstract] [Full Text] [Related]
11. [Indications for blood transfusion].
Hollán Z
Ter Arkh; 1989; 61(7):113-21. PubMed ID: 2511636
[No Abstract] [Full Text] [Related]
12. Transmission of viral hepatitis, type B, by plasma derivatives.
Barker LF; Hoofnagle JH
Dev Biol Stand; 1974; 27():178-88. PubMed ID: 4142771
[No Abstract] [Full Text] [Related]
13. Development of plasma derivatives for clinical use.
Tullis JL
Vox Sang; 1972; 23(1):3-9. PubMed ID: 4117048
[No Abstract] [Full Text] [Related]
14. Potentiation of the anti-factor VIII effect of thrombin in plasma by the plasminolytic derivatives of fibrinogen and fibrin.
Chandra S; Triantaphyllopoulos DC
Thromb Diath Haemorrh; 1973 Nov; 30(2):235-47. PubMed ID: 4272616
[No Abstract] [Full Text] [Related]
15. [Fractionation of plasma proteins and use of obtained preparations in clinical practice].
Cazal P; Graafland R
Probl Gematol Pereliv Krovi; 1967 Jun; 12(6):11-6. PubMed ID: 4186098
[No Abstract] [Full Text] [Related]
16. [Plasma substitutes].
Lutz H
Dtsch Med Wochenschr; 1969 Jun; 94(25):1336-9. PubMed ID: 4182110
[No Abstract] [Full Text] [Related]
17. Fractionation of plasma with polyethylene glycol.
Polson A; Ruiz-Bravo C
Vox Sang; 1972; 23(1):107-18. PubMed ID: 5081005
[No Abstract] [Full Text] [Related]
18. [Whole blood, plasma and plasma fractions].
HASSIG A
Praxis; 1960 Apr; 49():379-80. PubMed ID: 13851998
[No Abstract] [Full Text] [Related]
19. Present state and perspectives of the farctionation of human plasma, serum and placenta.
Richter P
Ann Immunol Hung; 1973; 17():85-92. PubMed ID: 4142679
[No Abstract] [Full Text] [Related]
20. Blood products.
Med Lett Drugs Ther; 1979 Nov; 21(23):93-6. PubMed ID: 502967
[No Abstract] [Full Text] [Related]
[Next] [New Search]
